Clarivate (NYSE:CLVT) Conference Transcript

Summary of Clarivate's Earnings Call Company Overview - Company: Clarivate - Industry: Information Services - Business Segments: - Intelligence Solutions (over 50% of services) - Workflow Solutions (SaaS) - Tech-Enabled Services (primarily in Intellectual Property) [3][4] Key Business Segments - Academia and Government: Accounts for about 50% of business; serves 99% of the world's top 400 institutions [4] - Intellectual Property: Represents about one-third of business; serves in-house legal departments and law firms [5] - Life Sciences and Healthcare: Provides solutions to top pharma and med tech companies [5] Financial Performance Highlights - Annual Contract Value (ACV): Growth improved from below 1% in 2024 to nearly 2% in 2025; guidance for 2026 is 2%-3% growth [7][8] - Organic Recurring Revenue Growth: Expected to accelerate from 0.5% in 2024 to between 1% and 2% in 2025 [9] - Adjusted EBITDA: Over $1 billion reported last year; expected profit margin expansion of 200 basis points by 2026 [10] - Free Cash Flow: Generated $365 million last year; anticipated to grow to about $400 million this year [11] Strategic Initiatives - Divestiture of Life Sciences Business: Aimed at focusing on higher growth segments (A&G and IP) and improving balance sheet quality [12][13] - Value Creation Plan: Focus on business model optimization, enhancing sales execution, accelerating innovation, and conducting a strategic review [17][18] - Recurring Revenue Focus: Shift from transactional to recurring revenue, aiming for 90% recurring revenue [37][38] AI and Innovation - AI Integration: Significant investments in AI across products, including research assistants and workflow agents [20][21] - Web of Science: Launch of AI-native platform to enhance analytics and research capabilities [26] - Efficiency Improvements: Independent studies show significant efficiency gains from AI implementations [27] Market Dynamics - A&G Segment: Improvement in renewal rates and contract value; strong funding for academic research expected to continue [42][43] - IP Segment Growth Drivers: Anticipated growth in patent filings due to sustained AI innovation; global patents in force have shown healthy growth [48][50] Capital Allocation - Deleveraging Focus: Plans to use free cash flow primarily for debt repayment; potential proceeds from the LS&H sale will also support this [55][56] Future Outlook - Success Metrics for 2026: Improved customer engagement with AI solutions, achievement of financial objectives, and continued organic growth in ACV and recurring revenue [57]